Ingelman-Sundberg M, Sim SC: Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 system. Biochem Biophys Res Commun 2010;396:90.
Kang MJ et al: The effect of gut microbiota on drug metabolism. Expert Opin Drug Metab Toxicol 2013;9:1295.
Kroemer HK, Klotz U: Glucuronidation of drugs: A reevaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 1992;23:292.
Kuehl P et al: Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001; 27:383.
Lindenbaum J et al: Inactivation of digoxin by the gut flora: Reversal by antibiotic therapy. N Engl J Med 1981;305:789.
Lown KS et al: Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997;99:2545.
Meyer UA: Pharmacogenetics—Five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 2004;5:669.
Morgan ET et al: Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos 2008;36:205.
Nelson DR et al: The P450 superfamily: Update on new sequences, gene mapping, accession numbers, and nomenclature. Pharmacogenetics 1996;6:1.
Nelson DR et al: Updated human P450 sequences. http://drnelson.uthsc.edu/ cytochromeP450.html.
Pirmohamed M: Drug-grapefruit juice interactions: Two mechanisms are clear but individual responses vary. Br Med J 2013;346:f1.
Posadzki P, Watson L, Ernst E: Herb-drug interactions: An overview of systematic reviews. Br J Clin Pharmacol 2013;75:603.
Rahimi R, Abdollahi M: An update on the ability of St. John’s wort to affect the metabolism of other drugs. Expert Opin Drug Metab Toxicol 2012;8:691.
Rieder MJ et al: Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005;352:2285.
Russo E et al: Hypericum perforatum: Pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res 2014;28:643.
Saitta KS et al: Bacterial beta-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: Mode of action and pharmacokinetics. Xenobiotica 2014;44:28.
Sueyoshi T, Negishi M: Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 2001;41:123.
Thummel KE, Wilkinson GR: In vitro and in vivo drug interactions involving human CYP3A. Annu Rev Pharmacol Toxicol 1998;38:389.
Tsai HH et al: Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: A systematic literature review. Int J Clin Pract 2012;66:1056.